Cite
HARVARD Citation
Hutton, B. et al. (2015). Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer – An inspection of the evidence base informing clinical decision-making. Cancer treatment reviews. 41 (10), pp. 951-959. [Online].